Loading... Please wait... Loading... Please wait...
ESTIMATED
05/07/2024
05/07/2024
(AS OF MARCH 31)
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 0 | -$0.07 | -$0.07 | -$0.07 |
| Q2 2024 | 2 | -$0.05 | -$0.05 | -$0.05 |
| Q3 2024 | 0 | -$0.05 | -$0.05 | -$0.05 |
| Q4 2024 | 0 | -$0.06 | -$0.06 | -$0.06 |
| Q1 2025 | 1 | -$0.05 | -$0.05 | -$0.05 |
| Q2 2025 | 1 | -$0.04 | -$0.04 | -$0.04 |
| Q3 2025 | 1 | -$0.05 | -$0.05 | -$0.05 |
| Q4 2025 | 1 | -$0.07 | -$0.07 | -$0.07 |
Clover Health Investments, Corp. last posted its earnings results on Tuesday, May 7th, 2024. The company reported $-0.05 earnings per share for the quarter, topping analysts' consensus estimates of $-0.07 by $0.02. The company had revenue of 346.46 M for the quarter and had revenue of 2.03 B for the year. Clover Health Investments, Corp. has generated $0 earnings per share over the last year ($-0.44 diluted earnings per share) and currently has a price-to-earnings ratio of -3.74. Clover Health Investments, Corp. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 6th, 2024 based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue | 05/07/2024 | Q1 2024 | -$0.07 | -$0.04 | 0.03 | $321.23 M | $346.46 M | 03/14/2024 | Q4 2023 | -$0.15 | $474.01 M | $505.44 M | 11/06/2023 | Q3 2023 | -$0.10 | -$0.09 | 0.01 | $482.07 M | 08/08/2023 | Q2 2023 | -$0.13 | -$0.06 | 0.07 | $513.63 M | 05/09/2023 | Q1 2023 | -$0.19 | -$0.15 | 0.04 | $498.73 M | $527.78 M | 03/01/2023 | Q4 2022 | -$0.13 | $785.48 M | $898.79 M | 11/07/2022 | Q3 2022 | -$0.31 | -$0.16 | 0.15 | $856.82 M | 08/08/2022 | Q2 2022 | -$0.23 | -$0.22 | 0.01 | $846.70 M | 05/09/2022 | Q1 2022 | -$0.24 | -$0.13 | 0.11 | $874.38 M | 02/28/2022 | Q4 2021 | -$0.26 | -$0.40 | -0.14 | $408.13 M | $432.04 M | 11/09/2021 | Q3 2021 | -$0.31 | -$0.08 | 0.23 | $413.10 M | $427.16 M | 08/11/2021 | Q2 2021 | -$0.17 | -$0.78 | -0.61 | $205.39 M | $412.47 M | 05/17/2021 | Q1 2021 | -$0.12 | -$0.13 | -0.01 | $200.33 M | 03/31/2021 | Q4 2020 | -$0.20 | $166.96 M | $166.23 M | 11/13/2020 | Q3 2020 | $0.03 | $169.07 M | 08/13/2020 | Q2 2020 | $0.01 | $172.08 M | 06/04/2020 | Q1 2020 | -$0.07 | $165.51 M | 12/30/2019 | Q4 2019 | $0.00 | $0 |
|---|
A. Clover Health Investments, Corp. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 6th, 2024 based off last year's report dates.
A. In the previous quarter, Clover Health Investments, Corp. (NASDAQ:CLOV) reported $-0.05 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.07 by $0.02.
A. The conference call for Clover Health Investments, Corp.'s latest earnings report can be listened to online.
A. The conference call transcript for Clover Health Investments, Corp.'s latest earnings report can be read online.
A. Clover Health Investments, Corp. (NASDAQ:CLOV) has a recorded annual revenue of $2.03 B.
A. Clover Health Investments, Corp. (NASDAQ:CLOV) has a recorded net income of $2.03 B. Clover Health Investments, Corp. has generated $-0.44 earnings per share over the last four quarters.
A. Clover Health Investments, Corp. (NASDAQ:CLOV) has a price-to-earnings ratio of -3.74 and price/earnings-to-growth ratio is -0.12.
